This is a working overview of synthetic peptide, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-10-21 and is reviewed periodically as new material appears.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form; may appear as cake |
| Solubility class | Water-soluble | Often reconstituted in aqueous buffer |
| Typical storage temperature | −20 °C or below | Protect from light and moisture |
| Typical analytical method | RP-HPLC and mass spectrometry | Used for purity and identity |
| Common synonyms | AOD-9604; AOD9604; hGH fragment 176-191 | Research name and fragment description |
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
Josh Allen became the first player to score a rushing touchdown, a receiving touchdown and multiple passing touchdowns in a single game. Bobby Wagner extended his streak of recording 100 tackles in a season to 13 years. He is the second player to record the feat, joining London Fletcher. Jayden Daniels became the first rookie to complete 80 percent of his passes, throw three touchdowns, and run for a touchdown in a single game. Jameis Winston became the first player in the Super Bowl era to have at least 400 passing yards, four passing touchdowns and two interceptions returned for touchdowns in a game. Justin Herbert became the third player to have at least 10 consecutive games without interception (minimum 15 attempts per game), joining Tom Brady and Derek Carr. The Pittsburgh Steelers tied the record for most consecutive seasons finishing with a winning percentage of .500 or better, with 21. They share the record with the Dallas Cowboys, who did so from 1965 to 1985. The Cincinnati Bengals tied the single-season record for most games lost while scoring at least 30 points, with four. They share the record with the 2002 Kansas City Chiefs. Week 14
In Indonesia, the National Transportation Safety Committee (NTSC; Indonesian: Komite Nasional Keselamatan Transportasi, KNKT) is responsible for the investigation of incidents and accidents, including air accidents. Its aim is the improvement of transportation safety, not just aviation, in Indonesia. Created in 1999 in Italy, the Agenzia Nazionale per la Sicurezza del Volo (ANSV), has two main tasks: conducting technical investigations for civil aviation aircraft accidents and incidents, while issuing safety recommendations as appropriate; and conducting studies and surveys aimed at increasing flight safety. The organization is also responsible for establishing and maintaining the "voluntary reporting system". Although not under the supervision of the Ministry of Infrastructure and Transport, the ANSV is a public authority under the oversight of the Presidency of the Council of Ministers of Italy.
A transcriptor is a transistor-like device composed of DNA and RNA rather than a semiconducting material such as silicon. Prior to its invention in 2013, the transcriptor was considered an important component to build biological computers. To function, a modern computer needs three different capabilities: It must be able to store information, transmit information between components, and possess a basic system of logic. Prior to March 2013, scientists had successfully demonstrated the ability to store and transmit data using biological components made of proteins and DNA. Simple two-terminal logic gates had been demonstrated, but required multiple layers of inputs and thus were impractical due to scaling difficulties.
After Runciter disappears, Jory reveals himself to Chip, telling him that he, not Conley, has now killed off the entire group (including Conley), as he "eats" half-lifers to sustain himself, and that the entire reality they are experiencing is created and maintained by him. Fortunately, Chip is temporarily protected from being consumed through the effect of Ubik, and leaves Jory. As he at last begins to deteriorate again, he meets Ella, who saves him by granting him a certificate for a life-long supply of Ubik, and instructs him to stay half-alive and seek cans of Ubik to further assist Runciter after she herself reincarnates. She states that Jory's family pays the facility to keep his body near other half-lifers for him to consume in order to prolong his own half-life, and that entities like Jory can arise in any collection of half-lifers. Ubik is claimed to have been developed by Ella and several other half-lifers as a defense against Jory. Each chapter is introduced by a commercial advertising Ubik as a different product serving a specific use. The last chapter is introduced by Ubik claiming that it has created and directed the universe, and that its real name is unknown and unspoken. In this short chapter, Runciter, who is in the "living" world mourning the loss of his best employees, discovers coins showing Chip's face, and feels that this is "just the beginning".
Sources: en.wikipedia.org
=== Industrial synthesis === The industrial synthesis of pantothenic acid starts with the aldol condensation of isobutyraldehyde and formaldehyde. The resulting hydroxypivaldehyde is converted to its cyanohydrin derivative. which is cyclised to give racemic pantolactone. This sequence of reactions was first published in 1904.
=== Cyanobacteria and the evolution of photosynthesis === The biochemical capacity to use water as the source for electrons in photosynthesis evolved once, in a common ancestor of extant cyanobacteria (formerly called blue-green algae). The geological record indicates that this transforming event took place early in Earth's history, at least 2450–2320 million years ago (Ma), and, it is speculated, much earlier. Because the Earth's atmosphere contained almost no oxygen during the estimated development of photosynthesis, it is believed that the first photosynthetic cyanobacteria did not generate oxygen. Available evidence from geobiological studies of Archean (>2500 Ma) sedimentary rocks indicates that life existed 3500 Ma, but the question of when oxygenic photosynthesis evolved is still unanswered. A clear paleontological window on cyanobacterial evolution opened about 2000 Ma, revealing an already-diverse biota of cyanobacteria. Cyanobacteria remained the principal primary producers of oxygen throughout the Proterozoic Eon (2500–543 Ma), in part because the redox structure of the oceans favored photoautotrophs capable of nitrogen fixation. Green algae joined cyanobacteria as the major primary producers of oxygen on continental shelves near the end of the Proterozoic, but only with the Mesozoic (251–66 Ma) radiations of dinoflagellates, coccolithophorids, and diatoms did the primary production of oxygen in marine shelf waters take modern form.
In 2013, the club was implicated in the longest-running anti-doping investigation in Australian sports history, which resulted in the club being fined, disqualified from the 2013 finals series, and stripped of draft picks, while 34 past and present players were ultimately suspended for the 2016 season. The team plays in two of the AFL's longest-running annual marquee fixtures: the Anzac Day clash with Collingwood (since 1995) and Dreamtime at the 'G with Richmond (since 2005). Three Essendon players—John Coleman, Bill Hutchison, and Reynolds—and coach Sheedy are elevated as "Legends" in the Australian Football Hall of Fame. In addition to its senior men's side, Essendon fields reserve men's and women's teams in the Victoria Football League and VFL Women's. Since 2022, the club has fielded a senior women's team in the national AFL Women's (AFLW) competition.
=== A public-health approach === A common critical view holds that the war on drugs has been costly and ineffective largely because US federal and state governments have chosen the wrong methods, focusing on interdiction and punishment rather than regulation and treatment of drug abuse and addiction. In the US, current public health-oriented interventions include harm reduction, drug courts, and Law Enforcement Assisted Diversion (LEAD) programs which give police treatment or social services options rather than arrest with minor drug offenses. Harm reduction approaches include provision of sterile syringes, medically supervised injection sites (SIF), and availability of the opioid overdose-countering drug naloxone. As an alternative to imprisonment, drug courts in the US identify substance-abusing offenders and place them under strict court monitoring and community supervision, as well as provide them with long-term treatment services. According to a National Drug Court Institute report, 16.4% of the nation's drug court graduates are rearrested and charged with a felony within one year of completing the program; overall 44.1% of released prisoners end up back in prison within one year. The drug court program is also significantly cheaper than imprisonment. Annual per offender cost is $20,000–$50,000 for imprisonment, and $2,500–$4,000 in the drug court system. A survey by the Substance Abuse and Mental Health Services Administration (SAMHSA) found that substance abusers who remain in treatment longer are less likely to resume their former drug habits.
A trap requires confining forces in all three spatial directions. Electric and magnetic fields exert forces on ions, called the Lorentz force. Due to Earnshaw's theorem it is not possible to confine an ion using only static electric fields. However, a static magnetic and electric field (a Penning trap), or the combination of an oscillating electric field with a static electric field (a Paul trap), can trap ions. The confining fields and the resulting motion of ions in a trap are generally decomposed into one axial and two radial components with respect to the trap geometry. In both Paul and Penning traps, a static electric field provides the axial confinement. Paul traps confine the ion radially with an oscillating electric field whereas Penning traps use a static magnetic field.
Sources: en.wikipedia.org
=== Pharmacokinetics === Metabolism of myristicin yields 3-methoxycatechol and enzymatically forms 5-allyl-1-methoxy-2,3-dihydroxybenzene (oxidation of the methylenedioxy group). Myristicin is also transformed into demethylenylmyristicin, dihydroxymyristicin, and elemicin is transformed into O-demethylelemicin, O-demethyldihydroxyelemicin, and safrole. There has been speculation that myristicin might be converted into the psychedelic MMDA, but this has not been demonstrated in humans. However, two nitrogen-containing metabolites of myristicin have been identified in the urine of rats and guinea pigs following oral or intraperitoneal administration. The major basic ninhydrin-positive urinary metabolite of myristicin in the rat is 3-piperidyl-1-(3′methoxy-4′,5′-methylenedioxyphenyl)-1-propanone, while the major basic ninhydrin-positive urinary metabolite of the guinea pig is 3-pyrrolidinyl-1-(3′methoxy-4′,5′-methylenedioxyphenyl)-1-propanone. Equivalent nitrogen-containing metabolites have also been identified for safrole and elemicin, including the dimethylamine, piperidine and pyrrolidine forms. Whether these aminated metabolites are involved in the reported psychoactive and hallucinogenic effects of botanical sources of these allylbenzenes like nutmeg is not known.
== Further reading == Kundu, Subhas C., ed. (2014). Silk Biomaterials for Tissue Engineering and Regenerative Medicine. Woodhead Publishing Series in Biomaterials. Woodhead Publishing. ISBN 978-0-85709-699-9. Vepari, Charu; Kaplan, David L. (2007). "Silk as a biomaterial". Progress in Polymer Science. 32 (8–9): 991–1007. doi:10.1016/j.progpolymsci.2007.05.013. PMC 2699289. PMID 19543442. Rockwood, Danielle N.; Preda, Rucsanda C.; Yücel, Tuna; Wang, Xiaoqin; Lovett, Michael L.; Kaplan, David L. (2011). "Materials fabrication from Bombyx mori silk fibroin". Nature Protocols. 6 (10): 1612–1631. doi:10.1038/nprot.2011.379. PMC 3808976. PMID 21959241.
Jollibee is a Filipino fast-food restaurant chain and the flagship brand of Jollibee Foods Corporation (JFC). Established in 1978 by Tony Tan Caktiong, it is the Philippines' top fast-food restaurant and is among the world's fastest-growing restaurant chains, having expanded its international presence almost sixfold from 2014 to 2024. As of January 2024, there were over 1,668 Jollibee fast-food restaurants, including more than 400 outside the Philippines, operating in 17 countries including Canada, Hong Kong, Macau, Malaysia, Singapore, the United Kingdom, the United States, and Vietnam, as well as across the Middle East. Jollibee is best known for its Chickenjoy fried chicken.
Opicapone, sold under the brand name Ongentys, is a medication which is administered together with levodopa in people with Parkinson's disease. Opicapone is a catechol-O-methyltransferase (COMT) inhibitor. The most common side effects are dyskinesia (difficulty controlling movement), constipation, increased blood creatine kinase, hypotension/syncope, and decreased weight. Opicapone, works to restore the levels of dopamine in the parts of the brain that control movement and coordination. It enhances the effects of levodopa, a precursor of the neurotransmitter dopamine that can be taken by mouth. Opicapone blocks an enzyme that breaks down levodopa in the body called catechol-O-methyltransferase (COMT). It is peripherally selective and does not inhibit COMT in the brain. As a result of its COMT inhibition, levodopa remains active for longer. This helps to improve the symptoms of Parkinson's disease, such as stiffness and slowness of movement. In June 2016, it was authorised for use in the European Union. It was authorised for use in the United States in April 2020.
== Further reading == Li, Qing. "日本人作家の見た中国 : 『李香蘭 私の半生』と『大地の子』から" [The Image of China from the viewpoint of Japanese writers (the sub-title refers to Fragrant Orchid and Child of the Earth)]. Journal of Matsusaka University (in Japanese) (10). Matsusaka University: 39–50. - Profile at CiNii. The other series documented is Child of the Earth.
Sources: en.wikipedia.org
Lyophilized powder is commonly stored at −20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept refrigerated and used within a limited period.
Reversed-phase HPLC and mass spectrometry are standard checks. They confirm peptide purity and molecular mass, but they do not by themselves demonstrate biological activity.
Synthesis, purification, and handling conditions can differ, leading to variations in purity and salt content. Certificates of analysis help, but independent testing is often needed for verification.
No. Major drug regulators have not approved AOD-9604 for weight loss or any other therapeutic indication. It remains an investigational compound studied in research settings.